{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:03Z","timestamp":1786119663179,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/iae.0b013e3181f2a27f","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T01:14:50Z","timestamp":1297127690000},"page":"866-870","source":"Crossref","is-referenced-by-count":24,"title":["ROLE OF INTRAVITREAL BEVACIZUMAB IN EALES DISEASE WITH DENSE VITREOUS HEMORRHAGE"],"prefix":"10.1097","volume":"31","author":[{"given":"Sourabh Dileep","family":"Patwardhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajvardhan","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin Mahendra","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yograj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","first-page":"262","article-title":"Retinal haemorrhage associated with epistaxis and constipation.","volume":"9","author":"Eales","year":"1880","journal-title":"Birmingham Med Rev"},{"key":"R2-7-20210130","first-page":"41","article-title":"Primary retinal haemorrhage in young men.","volume":"1","author":"Eales","year":"1882","journal-title":"Ophthalmic Rev"},{"key":"R3-7-20210130","first-page":"35","article-title":"Pars plana vitrectomy in vitreous hemorrhage due to Eales disease.","volume":"40","author":"Gadkari","year":"1992","journal-title":"Indian J Ophthalmol"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0896-1549(05)70081-X","article-title":"Eales disease: clinical features, pathophysiology, etiopathogenesis.","volume":"11","author":"Patnaik","year":"1998","journal-title":"Ophthalmol Clin North Am"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0039-6257(02)00288-6","article-title":"Eales disease-an update.","volume":"47","author":"Biswas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0420.2000.078001077.x","article-title":"Comparative evaluation of early vs. deffered vitrectomy in Eales disease.","volume":"78","author":"Kumar","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1006002204178","article-title":"Long term visual results of vitrectomy for Eales disease complications.","volume":"22","author":"Shanmugam","year":"1998","journal-title":"Int Ophthalmol"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.eye.6702763","article-title":"Surgical outcomes for vitrectomy in Eales disease.","volume":"22","author":"Shukla","year":"2008","journal-title":"Eye"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/bjo.86.11.1248","article-title":"Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales disease).","volume":"86","author":"El-Asrar","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0896-1549(05)70082-1","article-title":"Eales disease: medical, laser, and surgical treatments.","volume":"11","author":"Atmaca","year":"1998","journal-title":"Ophthalmol Clin North Am"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00006982-198808020-00002","article-title":"Vitrectomy for nondiabetic vitreous hemorrhage: retinal and choroidal vascular disorders.","volume":"8","author":"Smiddy","year":"1988","journal-title":"Retina"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1076\/ocii.10.3.213.15598","article-title":"A long-term follow-up of Eales disease.","volume":"10","author":"Atmaca","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/112067210501500311","article-title":"Therapeutic effects of laser photocoagulation and\/or vitrectomy in Eales disease.","volume":"15","author":"Dehghan","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3129\/can j ophthalmol.i07-026","article-title":"Rapid regression of disc and retinal neovascularisation in a case of Eales disease after intravitreal bevacizumab.","volume":"42","author":"Kumar","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09273940801923903","article-title":"Intravitreal injection of bevacizumab in Eales disease.","volume":"16","author":"Kucukerdonmez","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10792-009-9292-0","article-title":"Role of intravitreal bevacizumab in the management of Eales disease.","volume":"30","author":"Chanana","year":"2010","journal-title":"Int Ophthalmol"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/ICB.0b013e318178081a","article-title":"Spontaneous relief of vitreomacular traction and regression of neovascularisation in Eales disease after intravitreal injection of bevacizumab.","volume":"3","author":"Raju","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"R18-7-20210130","first-page":"S1","article-title":"Development and implementation of a Vitreous Hemorrhage Grading Scale.","volume":"3","author":"Lieberman","year":"2006","journal-title":"Retin Physician"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2002-30662","article-title":"Massive vascular endothelium growth factor (VEGF) expression in Eales disease.","volume":"219","author":"Perentes","year":"2002","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00417-008-0914-4","article-title":"Intravitreal Bevacizumab in active progressive proliferative diabetic retinopathy.","volume":"246","author":"Moradian","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-201105000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:52:25Z","timestamp":1786042345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201105000-00007"}},"subtitle":["A Prospective Randomized Control Study"],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181f2a27f","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}